Clinical trials
Phase 2 Aortic Aneurysm, Abdominal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Boston Scientific Corporation | 1 |
| Duke Vascular, Inc. | 1 |
| Imperial College London | 1 |
| Instituto de Investigación Hospital Universitario La Paz | 1 |
| Leiden University Medical Center | 1 |
| Mid Western Regional Hospital, Ireland | 1 |
| Naestved Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Aneurysm, Abdominal | 16 |
| Aneurysm | 2 |
| Atherosclerosis | 2 |
| Anemia | 1 |
| Aortic Aneurysm | 1 |
| Arterial Occlusive Diseases | 1 |
| Carotid Artery Diseases | 1 |
| Carotid Stenosis | 1 |
| Inflammation | 1 |
| Varicose Veins | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.